Project Grant R35GM166045
- The National Institute of General Medical Sciences awarded the University of Illinois $380,350 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to systematically characterize human disease-associated protein complexes. The recipient will develop machine learning approaches to identify biologically relevant protein complex variants from over 32,000 mass spectrometry experiments, construct cell-type-specific protein complex maps focusing on early embryonic...
- The National Institute of General Medical Sciences awarded the University of Illinois $2,101,232 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop quantitative computational approaches that probe diverse biological processes and relate their outcomes to molecular structure and motion. The project will develop computational methods ranging from atomistic molecular dynamics to continuum simulations, guided by unmet needs in basic biomedical...
- The National Institute of General Medical Sciences awarded the University of Illinois $113,211 on September 3, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop mass spectrometry-based instrumentation and computational tools for spatiotemporal neuropeptidomics with isomer-resolved capabilities. The work will map neuropeptide distribution and release with high spatial and temporal resolution and increased throughput, creating new molecular signatures of...
- The National Institute of General Medical Sciences awarded The University of Chicago $1,725,379 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing R01GM166338) to develop spatially-informed artificial intelligence tools that jointly analyze single-cell RNA-sequencing and spatial transcriptomics data to infer and quantify niche-dependent cell-state transitions in tissue contexts. The project delivers inference methods for spatial...
- The National Institute of General Medical Sciences awarded the University of Illinois $303,685 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to discover and characterize RIPP biosynthetic enzymes. The work focuses on assigning catalytic function to domains of unknown function (DUFs) encoded in microbial genomes, particularly those involved in ribosomally synthesized and posttranslationally modified peptides (RIPPs) biosynthesis. The research...
- The National Institute of General Medical Sciences awarded $357,809 to The University of Chicago on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop sequence-based artificial intelligence frameworks for decoding genome regulation. The award funds development of three key research pillars: explainable sequence models that discover simple rules for diverse regulatory functions; novel architectures to predict long-range regulatory interactions...
- The National Institute of General Medical Sciences awarded The University of Chicago $451,000 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop statistical methods linking genetic variants to regulatory landscapes and disease mechanisms. The award funds research to move beyond cis gene regulation toward trans regulation of genes and proteins and genetic regulation of the epigenome. Specific deliverables include comprehensively mapping...
- The National Institute of General Medical Sciences awarded the University of Illinois $372,016 on July 7, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to deconstruct RNA polymerase III regulation and function through systematic profiling of POL III activity and discovery of new regulatory mechanisms. The research applies genomic and biochemical strategies to characterize POL III transcription breadth and tissue-specific patterns, focusing initially on the...
- The National Institute of General Medical Sciences awarded The University of Chicago $410,000 on March 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods enhancing causal inference in genetics and genomics over a five-year period through December 31, 2030. The research addresses confounding and generalizability barriers in Mendelian randomization and single-cell CRISPR screening by creating statistical and machine learning tools...
- The National Institute of General Medical Sciences awarded The University of Chicago $602,095 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the structure and function of molecular machines involved in protein and RNA modifications. Over the five-year performance period ending June 30, 2031, the laboratory will conduct integrated structural and biochemical studies of three interconnected systems: the ubiquitin-proteasome pathway...
The National Institute of General Medical Sciences awarded the University of Illinois $395,194 on July 21, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop interpretable machine learning models for decoding cellular dynamics in single-cell and spatial omics datasets. The project will design multimodal machine learning approaches that integrate transcriptomics, imaging data, and text-based knowledge to disentangle gene programs and cellular factors that drive morphological features and abnormal cellular behaviors. The work will leverage perturbation datasets to model how genetic perturbations, cell-intrinsic properties, and environmental changes influence cell-state transitions, enabling large-scale therapeutic screening. Researchers will generate synthetic spatial transcriptomics data and create disentangled cell representations across diverse single-cell study contexts to improve interpretability of how distinct biological factors influence cellular behavior. The University of Illinois at Chicago is the recipient. Performance occurs in Chicago, Illinois. The award period runs through April 30, 2031. This is a Project Grant, the assistance type under which NIGMS supports investigator-initiated basic research that advances understanding of biological processes and lays the foundation for disease diagnosis, treatment, and prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $395.2k | 7/21/26 |